ASX 200 Blue-Chip Shares: ALD and CSL Linger Below Year-Start Levels Despite Sector Recovery

June 17, 2025 04:16 PM AEST | By Team Kalkine Media

Google News:

ASX 200 Blue-Chip Shares: ALD and CSL Linger Below Year-Start Levels Despite Sector Recovery — Image source: Shutterstock

Recent News

Pro Medicus (ASX:PME) Strengthens Position in Radiology Software Secto...

Light & Wonder (ASX:LNW) Gains Spotlight in ASX 200 Gaming Sector

Global energy stocks dip as US Senate moves to end wind, solar tax cre...

ASX 200: Real Estate and Tech Lift Sentiment Amid Market Caution

Highlights

Ampol Ltd (ASX:ALD) underperforms while the ASX 200 Energy index sees overall gains in 2025

CSL Ltd (ASX:CSL) continues downward trajectory, nearing long-term lows despite ASX 100 stability

Broker insights signal room for recovery as both companies hold leading market positions in their sectors

Ampol Ltd (ASX:ALD), a major player within the ASX 200 and ASX 50, is ranked among Australia's top energy firms by market capitalisation. Despite its significant scale, the share price remains below its levels at the start of the year. This decline contrasts with the broader ASX 200 Energy index, which has seen gains in 2025.

International factors, including developments in US trade policies, may have influenced early year volatility. Yet, the fundamentals of the business and its entrenched role in energy supply remain unchanged. The broader sector’s performance this year may highlight a divergence, where Ampol’s pricing remains subdued relative to peers.

Market expectations indicate there may be room for share price movement. Notably, ALD has also been a mention in asx dividends discussions due to its consistent income distribution history.

Healthcare Dip: CSL Ltd (ASX:CSL)

CSL Ltd (ASX:CSL) is a biotechnology and healthcare leader within the ASX 100, ASX 200, and ASX 300 indices. As the largest healthcare company on the exchange, its global presence spans North America, Asia, and Australia.

Despite a solid earnings report, the stock has tracked downward this year, falling near a long-term low. Market sentiment appeared affected by broader macroeconomic concerns and cross-border operations, particularly in the US and China. This is in contrast to a relatively resilient performance across the All Ordinaries healthcare names.

The company’s operations in high-demand therapeutic areas, especially in plasma-derived treatments and vaccine technologies, reinforce its market relevance. Broker outlooks currently place CSL in a favourable position, indicating confidence in its future trajectory.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.